Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes - Kidney International Supplements
Effect of Spironolactone on Cardiovascular Complications Associated with Type-2 Diabetes in Rats
Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril a
Spironolactone - Wikipedia
Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients
PDF) Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan | Hoda Atef - Academia.edu
Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double‐blind, randomized controlled VaSera trial - Faconti -
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial - The Lancet
JCM | Free Full-Text | Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease
PDF) Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy
Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension | Journal of Human Hypertension
Spironolacton und Hyperkaliämiegefahr – Rosenfluh.ch
Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension | Hypertension
:max_bytes(150000):strip_icc()/spironolactone-for-weight-loss-4178700_color4-5c26575b46e0fb000125c5e4.png "Spironolactone for Weight Loss: Uses, Side Effects, Dosages")
Spironolactone for Weight Loss: Uses, Side Effects, Dosages
Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT) | Hypertension
Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles | SpringerLink
Effect of low-dose spironolactone on resistant hypertension in type 2 diabetes mellitus: a randomized controlled trial in a sub-Saharan African population | BMC Research Notes | Full Text
Frontiers | Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling
Spironolactone Does Not Prevent Diabetic Nephropathy in Type 2 Diabetes - Renal and Urology News
The Effects of Adding Spironolactone to ACEI or ARB on Proteinuria in Type 2 Diabetes | Semantic Scholar
17- A Simple Checklist to Control High-Risk Type 2 Diabetes
SPIRONOLACTON Accord 25 mg Filmtabletten - Beipackzettel | Apotheken Umschau
The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy | Bentham Science
Treating resistant hypertension in type 2 diabetes: a role for spironolactone? - Adrian G Stanley, Philip Swales, Herbert Thurston, Bryan Williams, 2006
Baseline urinary metabolites predict albuminuria response to spironolactone in type 2 diabetes - ScienceDirect
